Industries > Pharma > Global Erythropoietin Market Forecast 2017-2027

Global Erythropoietin Market Forecast 2017-2027

Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing

PUBLISHED: 28 April 2017
PAGES: 164
PRODUCT CODE: PHA0187
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0187 Categories: , Tag:

The global erythropoietin market is expected to grow at a CAGR of 7.8% in the first half of the forecast period and CAGR of 4.8% in the second half of the forecast period. The market is estimated at $7.9bn in 2016 and $16.5bn in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 84 tables and 93 figures – all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global erythropoietin market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Erythropoietin Market forecasts from 2017-2027

• Revenue forecasts of global erythropoietin market, segmented by product type:
– Epoetin Alfa
– Epoetin Beta
– Darbepoetin Alfa
– Biosimilars
– Others

This section also discusses the leading drugs as well as SWOT analysis of each submarket.

• Revenue forecasts of global erythropoietin market, segmented by application:
– Anemia (Cancer and HIV Treatment)
– Kidney Disorders (ESRD and Dialysis)
– Others

• Revenue forecasts of global erythropoietin API manufacturing market, segmented by contract manufacturing and in-house manufacturing

• Erythropoietin Leading Regional Market forecasts from 2017-2027 covering North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Global Erythropoietin Market Forecast 2017-2027

Forecast for each regional market is further segmented by product type, application and country:
– US
– Canada
– UK
– Germany
– France
– Spain
– Italy
– Rest of Europe
– China
– Japan
– India
– Rest of Asia-Pacific
– Brazil
– Mexico
– Rest of Latin America
– Saudi Arabia
– South Africa
– Rest of Middle East and Africa

• Assessment of selected leading companies that hold major market shares in the erythropoietin market:
– Amgen
– Johnson & Johnson
– Roche
– Biocon
– 3SBio
– Pfizer
– Kyowa Hakko Kirin Co Ltd
– LG Life Sciences Limited
– Intas Pharmaceuticals Ltd
– Novartis AG

Visiongain’s study is intended for anyone requiring commercial analyses for the erythropoietin market. You find data, trends and predictions.

Buy our report today Global Erythropoietin Market Forecast 2017-2027: Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Erythropoietin Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Erythropoietin Market Forecast 2017-2027


Latest Pharma news

“The colon targeting drug delivery market will grow with exponential growth of 14% over the forecast period from 2020-2030”, says Visiongain

The colon targeting drug delivery market has been used various polymers including biodegradable polymers, guar gum, pectin, chondroitin sulfate, dextran, chitosan, cyclodextrin, inulin, amylose, locust bean gum, and others

23 September 2019

READ

“Global Diagnostic Imaging market set to grow to $32bn by 2024” says Visiongain report

Diagnostic imaging technology such as MRI and CT scans has become more precise and accessible, due to which radiology has increasingly become a key foundation of modern medicine.

20 September 2019

READ

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

READ

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

READ

Categories

Category